ÂÜÀòÂÒÂ×

Jason Hoitt is an experienced executive in the pharmaceutical industry, currently serving as Chief Commercial Officer at Stoke Therapeutics since April 2024. Prior roles include Chief Commercial Officer at Provention Bio from January 2020 to June 2023, and Dova Pharmaceuticals from December 2018 to November 2019. Jason has also held leadership positions at Insmed Incorporated and Sarepta Therapeutics, as well as various roles at Vertex Pharmaceuticals, Gilead Sciences, Schering, and AstraZeneca. Jason's educational background includes a Bachelor of Arts in Pre-Medicine/Pre-Medical Studies and Spanish from the College of the Holy Cross, a Certificate Program in Corporate Finance, Accounting, Marketing, and Organizational Leadership from Columbia University, and studies in Spanish Language and Literature at Universitat de les Illes Balears.